Skip to main content

Improving the control of epilepsy by combining a diet and a drug

Improving the control of epilepsy by combining a diet and a drug

  • Date16 October 2018

Research carried out by a team from the Centre for Biomedical Sciences, Royal Holloway, University of London, and published today in Epilepsia, may have identified a new way to help patients with epilepsy by combining a high-fat diet with low doses of an epilepsy drug.

Diet and Drugs for epilepsy

Combining diet with low doses of an epilepsy drug.

It has long been recognised that some epilepsy patients, particularly children, can benefit from a high fat, low carbohydrate ‘ketogenic’ diet, where the activity of the diet was thought to be through the production of chemicals called ‘ketones’.

However, recent work led by Professor Robin Williams, from Royal Holloway’s Centre for Biomedical Sciences, suggest that it is fatty acids provided in the diet that block seizures, by inhibiting specific receptors in the brain.

In a collaboration with Professor Matthew Walker at the Institute of Neurology, University College London, and Dr Philip Chen also from Royal Holloway’s Centre for Biomedical Sciences, the team suggested that the diet could be combined with the drug Perampanel which is used to help reduce epileptic seizures by acting on the same receptors.

Professor Williams said: “The drug can have serious side effects and doesn’t work for all patients. Our research however, suggests that combining a lower dose of the drug with a high-fat diet may benefit some sufferers, and reduce the risk of side-effects”.

Professor Walker said: “In the past people have tried to understand how the ketones impacted on the epilepsy. Our work shows that fatty acids are likely to provide control of seizures, and combining dietary fatty acids and perampanel is likely to work in epilepsy treatment.”

Dr Chen said: “This provides an unusual example of drug and dietary therapy acting together. What we are seeing here is more complicated than simply taking a drug. It is about reducing the level of the drug required and combining it with a very specific diet”.

“The next step is to move towards clinical studies, to show this improvement in treatment in patients” Professor Williams added.

There are around 600,000 people with epilepsy in the UK and 1 in 220 children are diagnosed with the condition. Around 30 per cent of sufferers continue to have seizures despite treatment, so this work offers a potentially exciting advance in finding new treatments.

The full title of the paper is: Perampanel and decanoic acid show synergistic action against AMPA receptors and seizures

The paper will be published in Epilepsia
DOI: 10.1111/epi.14578

Explore Royal Holloway

Get help paying for your studies at Royal Holloway through a range of scholarships and bursaries.

There are lots of exciting ways to get involved at Royal Holloway. Discover new interests and enjoy existing ones.

Heading to university is exciting. Finding the right place to live will get you off to a good start.

Whether you need support with your health or practical advice on budgeting or finding part-time work, we can help.

Discover more about our 21 departments and schools.

Find out why Royal Holloway is in the top 25% of UK universities for research rated ‘world-leading’ or ‘internationally excellent’.

Royal Holloway is a research intensive university and our academics collaborate across disciplines to achieve excellence.

Discover world-class research at Royal Holloway.

Discover more about who we are today, and our vision for the future.

Royal Holloway began as two pioneering colleges for the education of women in the 19th century, and their spirit lives on today.

We’ve played a role in thousands of careers, some of them particularly remarkable.

Find about our decision-making processes and the people who lead and manage Royal Holloway today.